Quality of life as a primary endpoint in ovarian cancer trials
Standard
Quality of life as a primary endpoint in ovarian cancer trials. / Mahner, Sven; Burges, Alexander.
In: LANCET ONCOL, Vol. 15, No. 4, 01.04.2014, p. 363-364.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
Mahner, S & Burges, A 2014, 'Quality of life as a primary endpoint in ovarian cancer trials', LANCET ONCOL, vol. 15, no. 4, pp. 363-364. https://doi.org/10.1016/S1470-2045(14)70084-1
APA
Mahner, S., & Burges, A. (2014). Quality of life as a primary endpoint in ovarian cancer trials. LANCET ONCOL, 15(4), 363-364. https://doi.org/10.1016/S1470-2045(14)70084-1
Vancouver
Mahner S, Burges A. Quality of life as a primary endpoint in ovarian cancer trials. LANCET ONCOL. 2014 Apr 1;15(4):363-364. https://doi.org/10.1016/S1470-2045(14)70084-1
Bibtex
@article{6b4313b87031445c992aef93f8901618,
title = "Quality of life as a primary endpoint in ovarian cancer trials",
author = "Sven Mahner and Alexander Burges",
note = "Document Type: Editorial Material",
year = "2014",
month = apr,
day = "1",
doi = "10.1016/S1470-2045(14)70084-1",
language = "English",
volume = "15",
pages = "363--364",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",
}
RIS
TY - JOUR
T1 - Quality of life as a primary endpoint in ovarian cancer trials
AU - Mahner, Sven
AU - Burges, Alexander
N1 - Document Type: Editorial Material
PY - 2014/4/1
Y1 - 2014/4/1
U2 - 10.1016/S1470-2045(14)70084-1
DO - 10.1016/S1470-2045(14)70084-1
M3 - Other (editorial matter etc.)
C2 - 24582485
VL - 15
SP - 363
EP - 364
JO - LANCET ONCOL
JF - LANCET ONCOL
SN - 1470-2045
IS - 4
ER -
